[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#pubInfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0001087",
    "@type" : [ "https://w3id.org/biolink/vocab/Disease" ]
  }, {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0001087"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/DRUGBANK:DB01267"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved."
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#context"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "https://pubmed.ncbi.nlm.nih.gov/31096228"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://w3id.org/um/neurodkg/OffLabelIndication"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#context",
    "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Adolescents (15-17)"
    } ]
  }, {
    "@id" : "https://identifiers.org/DRUGBANK:DB01267",
    "@type" : [ "https://w3id.org/biolink/vocab/Drug" ]
  } ],
  "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-24T16:13:47.586648"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-24T16:13:47.586648"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "GqT07hBN6al0Vf9zMLUZYNzBCP2WgoGtVEi1VIIjzx7DszQkCsPChUxAeFYXFkkJTi/Z/qgmVFi2SvV79CLKc13RJvQXvBfyFBBGGGCFmfnKTMBESghqW8/+WwQLkPz6tOUzfoJxKW5+LWXCcq5p2gN+XVWWYcOk9CFa/O50QMs="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#pubInfo"
} ]